Trial Outcomes & Findings for PALISADE Follow-on Study (ARC004) (NCT NCT02993107)
NCT ID: NCT02993107
Last Updated: 2022-03-17
Results Overview
Percentage of subjects ages 4-17 with at-least 1 TEAE, including serious adverse events, during the overall study period. The percentage of subjects reporting at least 1 TEAE by maximum reported severity is also presented using the 5-point CTCAE severity grading scale. All safety evaluations were conducted using the safety population (all subjects who received at least 1 dose of AR101 during ARC004), age 4-17 years. Safety data are presented for group 1 (former placebo) and Group 2 data are divided into columns for cohort 1 (QD), cohort 2 (overall), cohort 3A (QD), and cohorts 3B and 3C (overall).
Recruitment status
COMPLETED
Study phase
PHASE3
Target enrollment
388 participants
Primary outcome timeframe
Up to 126 weeks
Results posted on
2022-03-17
Participant Flow
Participant milestones
| Measure |
Group 1 (Placebo Crossovers)
Received AR101 during IDE (day 1, 0.5 to 3 or 6 mg; day 2, 3 mg), up-dosing (3-300 mg/day for 22-40 weeks, with dose escalations every 2 weeks), and maintenance (300 mg/day for 24-28 weeks).
|
Group 2: Cohort 1 (Active Rollovers)
Received 300 mg/day (once daily, QD) peanut protein for 28 weeks
|
Group 2: Cohort 2 (Active Rollovers)
Received 300 mg peanut protein every other day (QOD) for 4 weeks, then twice weekly (BIW) for 24 weeks for a total of 28 weeks
|
Group 2: Cohort 3A (Active Rollovers)
Received 300 mg/day peanut protein for 56 weeks
|
Group 2: Cohort 3B (Active Rollovers)
Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, then BIW for 24 weeks (total of 56 weeks)
|
Group 2: Cohort 3C (Active Rollovers)
Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, BIW for 24 weeks, then once weekly (QW) for 28 weeks (total of 84 weeks)
|
|---|---|---|---|---|---|---|
|
Overall Study
STARTED
|
113
|
120
|
50
|
35
|
34
|
36
|
|
Overall Study
Adverse Event
|
12
|
4
|
1
|
1
|
3
|
5
|
|
Overall Study
Physician Decision
|
1
|
0
|
1
|
0
|
0
|
0
|
|
Overall Study
Withdrawal by Subject
|
32
|
7
|
7
|
3
|
6
|
2
|
|
Overall Study
Lost to Follow-up
|
0
|
1
|
0
|
0
|
0
|
1
|
|
Overall Study
Sponsor Decision
|
4
|
0
|
1
|
1
|
0
|
4
|
|
Overall Study
Protocol Deviation
|
0
|
0
|
0
|
0
|
1
|
0
|
|
Overall Study
Other Reasons
|
2
|
1
|
1
|
1
|
2
|
3
|
|
Overall Study
COMPLETED
|
62
|
107
|
39
|
29
|
22
|
21
|
|
Overall Study
NOT COMPLETED
|
51
|
13
|
11
|
6
|
12
|
15
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
PALISADE Follow-on Study (ARC004)
Baseline characteristics by cohort
| Measure |
Group 1 (Placebo Crossovers)
n=111 Participants
Received AR101 during IDE (day 1, 0.5 to 3 or 6 mg; day 2, 3 mg), up-dosing (3-300 mg/day for 22-40 weeks, with dose escalations every 2 weeks), and maintenance (300 mg/day for 24-28 weeks)
|
Group 2: Cohort 1 (Active Rollovers)
n=117 Participants
Received 300 mg/day (once daily, QD) peanut protein for 28 weeks
|
Group 2: Cohort 2 (Active Rollovers)
n=48 Participants
Received 300 mg peanut protein every other day (QOD) for 4 weeks, then twice weekly (BIW) for 24 weeks for a total of 28 weeks
|
Group 2: Cohort 3A (Active Rollovers)
n=35 Participants
Received 300 mg/day peanut protein for 56 weeks
|
Group 2: Cohort 3B (Active Rollovers)
n=34 Participants
Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, then BIW for 24 weeks (total of 56 weeks)
|
Group 2: Cohort 3C (Active Rollovers)
n=36 Participants
Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, BIW for 24 weeks, then once weekly (QW) for 28 weeks (total of 84 weeks)
|
Total
n=381 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|---|
|
Age, Customized
Age 18-55 years
|
11 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
3 Participants
n=21 Participants
|
2 Participants
n=8 Participants
|
30 Participants
n=8 Participants
|
|
Age, Customized
Age 4-17 years
|
100 Participants
n=5 Participants
|
109 Participants
n=7 Participants
|
46 Participants
n=5 Participants
|
31 Participants
n=4 Participants
|
31 Participants
n=21 Participants
|
34 Participants
n=8 Participants
|
351 Participants
n=8 Participants
|
|
Sex: Female, Male
Female
|
39 Participants
n=5 Participants
|
55 Participants
n=7 Participants
|
22 Participants
n=5 Participants
|
16 Participants
n=4 Participants
|
13 Participants
n=21 Participants
|
17 Participants
n=8 Participants
|
162 Participants
n=8 Participants
|
|
Sex: Female, Male
Male
|
72 Participants
n=5 Participants
|
62 Participants
n=7 Participants
|
26 Participants
n=5 Participants
|
19 Participants
n=4 Participants
|
21 Participants
n=21 Participants
|
19 Participants
n=8 Participants
|
219 Participants
n=8 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
13 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
1 Participants
n=21 Participants
|
1 Participants
n=8 Participants
|
31 Participants
n=8 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
98 Participants
n=5 Participants
|
108 Participants
n=7 Participants
|
45 Participants
n=5 Participants
|
31 Participants
n=4 Participants
|
33 Participants
n=21 Participants
|
35 Participants
n=8 Participants
|
350 Participants
n=8 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
1 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
1 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Asian
|
7 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
3 Participants
n=4 Participants
|
1 Participants
n=21 Participants
|
3 Participants
n=8 Participants
|
35 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
1 Participants
n=8 Participants
|
1 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Black or African American
|
3 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
7 Participants
n=8 Participants
|
|
Race (NIH/OMB)
White
|
86 Participants
n=5 Participants
|
92 Participants
n=7 Participants
|
33 Participants
n=5 Participants
|
28 Participants
n=4 Participants
|
30 Participants
n=21 Participants
|
28 Participants
n=8 Participants
|
297 Participants
n=8 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
15 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
2 Participants
n=21 Participants
|
4 Participants
n=8 Participants
|
40 Participants
n=8 Participants
|
PRIMARY outcome
Timeframe: Up to 126 weeksPercentage of subjects ages 4-17 with at-least 1 TEAE, including serious adverse events, during the overall study period. The percentage of subjects reporting at least 1 TEAE by maximum reported severity is also presented using the 5-point CTCAE severity grading scale. All safety evaluations were conducted using the safety population (all subjects who received at least 1 dose of AR101 during ARC004), age 4-17 years. Safety data are presented for group 1 (former placebo) and Group 2 data are divided into columns for cohort 1 (QD), cohort 2 (overall), cohort 3A (QD), and cohorts 3B and 3C (overall).
Outcome measures
| Measure |
Group 1 (Overall)
n=100 Participants
Received AR101 during IDE (day 1, 0.5 to 3 or 6 mg; day 2, 3 mg), up-dosing (3-300 mg/day for 22-40 weeks, with dose escalations every 2 weeks), and maintenance (300 mg/day for 24-28 weeks).
|
Group 2: Cohort 1 (QD)
n=109 Participants
Received 300 mg/day (once daily, QD) peanut protein for 28 weeks
|
Group 2: Cohort 2 (Overall)
n=46 Participants
Received 300 mg peanut protein every other day (QOD) for 4 weeks, then twice weekly (BIW) for 24 weeks for a total of 28 weeks
|
Group 2: Cohort 3A (QD)
n=31 Participants
Received 300 mg/day peanut protein for 56 weeks
|
Group 2: Cohort 3B (Overall)
n=31 Participants
Cohort 3B: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, then BIW for 24 weeks (total of 56 weeks)
|
Group 2: Cohort 3C (Overall)
n=34 Participants
Cohort 3C: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, BIW for 24 weekly (QW) for 28 weeks (total 84 weeks)
|
|---|---|---|---|---|---|---|
|
Percentage of Subjects Ages 4-17 With Treatment-related Adverse Events (TEAE)
Grade 1: Mild
|
37 Participants
|
58 Participants
|
22 Participants
|
15 Participants
|
13 Participants
|
12 Participants
|
|
Percentage of Subjects Ages 4-17 With Treatment-related Adverse Events (TEAE)
Grade 2: Moderate
|
58 Participants
|
29 Participants
|
14 Participants
|
12 Participants
|
15 Participants
|
18 Participants
|
|
Percentage of Subjects Ages 4-17 With Treatment-related Adverse Events (TEAE)
Grade 4: Life-Threatening
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Percentage of Subjects Ages 4-17 With Treatment-related Adverse Events (TEAE)
All AEs
|
98 Participants
|
90 Participants
|
36 Participants
|
27 Participants
|
28 Participants
|
33 Participants
|
|
Percentage of Subjects Ages 4-17 With Treatment-related Adverse Events (TEAE)
SAEs
|
0 Participants
|
1 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
1 Participants
|
|
Percentage of Subjects Ages 4-17 With Treatment-related Adverse Events (TEAE)
Grade 3: Severe
|
3 Participants
|
3 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
3 Participants
|
|
Percentage of Subjects Ages 4-17 With Treatment-related Adverse Events (TEAE)
Grade 5: Death
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: Up to 126 weeksThe percentage of subjects who tolerated each the of 300 mg, 600 mg, 1000 mg, or 2000 mg challenge doses with no more than mild symptoms at exit DBPCFC. Analyses based on DBPCFCs used the completer population (age 4-17 years).
Outcome measures
| Measure |
Group 1 (Overall)
n=72 Participants
Received AR101 during IDE (day 1, 0.5 to 3 or 6 mg; day 2, 3 mg), up-dosing (3-300 mg/day for 22-40 weeks, with dose escalations every 2 weeks), and maintenance (300 mg/day for 24-28 weeks).
|
Group 2: Cohort 1 (QD)
n=103 Participants
Received 300 mg/day (once daily, QD) peanut protein for 28 weeks
|
Group 2: Cohort 2 (Overall)
n=38 Participants
Received 300 mg peanut protein every other day (QOD) for 4 weeks, then twice weekly (BIW) for 24 weeks for a total of 28 weeks
|
Group 2: Cohort 3A (QD)
n=26 Participants
Received 300 mg/day peanut protein for 56 weeks
|
Group 2: Cohort 3B (Overall)
n=22 Participants
Cohort 3B: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, then BIW for 24 weeks (total of 56 weeks)
|
Group 2: Cohort 3C (Overall)
n=21 Participants
Cohort 3C: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, BIW for 24 weekly (QW) for 28 weeks (total 84 weeks)
|
|---|---|---|---|---|---|---|
|
Percentage of Subjects Ages 4-17 Responding to Each Challenge Dose at Exit DBPCFC (Double-blind, Placebo-controlled Food Challenge)
Percentage (and 95% CI) tolerating 300 mg
|
98.6 Percent of participants
Interval 92.5 to 100.0
|
98.1 Percent of participants
Interval 93.2 to 99.8
|
94.7 Percent of participants
Interval 82.3 to 99.4
|
100.0 Percent of participants
Interval 86.8 to 100.0
|
81.8 Percent of participants
Interval 59.7 to 94.8
|
90.5 Percent of participants
Interval 69.6 to 98.8
|
|
Percentage of Subjects Ages 4-17 Responding to Each Challenge Dose at Exit DBPCFC (Double-blind, Placebo-controlled Food Challenge)
Percentage (and 95% CI) tolerating 600 mg
|
86.1 Percent of participants
Interval 75.9 to 93.1
|
89.3 Percent of participants
Interval 81.7 to 94.5
|
71.1 Percent of participants
Interval 54.1 to 84.6
|
96.2 Percent of participants
Interval 80.4 to 99.9
|
77.3 Percent of participants
Interval 54.6 to 92.2
|
76.2 Percent of participants
Interval 52.8 to 91.8
|
|
Percentage of Subjects Ages 4-17 Responding to Each Challenge Dose at Exit DBPCFC (Double-blind, Placebo-controlled Food Challenge)
Percentage (and 95% CI) tolerating 1000 mg
|
72.2 Percent of participants
Interval 60.4 to 82.1
|
80.6 Percent of participants
Interval 71.6 to 87.7
|
57.9 Percent of participants
Interval 40.8 to 73.7
|
96.2 Percent of participants
Interval 80.4 to 99.99
|
68.2 Percent of participants
Interval 45.1 to 86.1
|
66.7 Percent of participants
Interval 43.0 to 85.4
|
|
Percentage of Subjects Ages 4-17 Responding to Each Challenge Dose at Exit DBPCFC (Double-blind, Placebo-controlled Food Challenge)
Percentage (and 95% CI) tolerating 2000 mg
|
51.4 Percent of participants
Interval 39.3 to 63.3
|
48.5 Percent of participants
Interval 38.6 to 58.6
|
36.8 Percent of participants
Interval 21.8 to 54.0
|
80.8 Percent of participants
Interval 60.6 to 93.4
|
45.5 Percent of participants
Interval 24.4 to 67.8
|
42.9 Percent of participants
Interval 21.8 to 66.0
|
Adverse Events
Group 1 (Age 4-17 Overall)
Serious events: 0 serious events
Other events: 98 other events
Deaths: 0 deaths
Group 2: Cohort 1 (Age 4-17 QD)
Serious events: 1 serious events
Other events: 90 other events
Deaths: 0 deaths
Group 2: Cohort 2 (Age 4-17 Overall)
Serious events: 0 serious events
Other events: 36 other events
Deaths: 0 deaths
Group 2: Cohort 3A (Age 4-17 QD)
Serious events: 0 serious events
Other events: 27 other events
Deaths: 0 deaths
Group 2: Cohort 3B (Age 4-17 Overall)
Serious events: 1 serious events
Other events: 28 other events
Deaths: 0 deaths
Group 2: Cohort 3C (Age 4-17 Overall)
Serious events: 1 serious events
Other events: 33 other events
Deaths: 0 deaths
Group 1 (Age 18-55 Overall)
Serious events: 0 serious events
Other events: 10 other events
Deaths: 0 deaths
Group 2: Cohort 1 (Age 18-55 QD)
Serious events: 1 serious events
Other events: 6 other events
Deaths: 0 deaths
Group 2: Cohort 2 (Age 18-55 Overall)
Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths
Group 2: Cohort 3A (Age 18-55 QD)
Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths
Group 2: Cohort 3B (Age 18-55 Overall)
Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths
Group 2: Cohort 3C (Age 18-55 Overall)
Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
Group 1 (Age 4-17 Overall)
n=100 participants at risk
Received AR101 during IDE (day 1, 0.5 to 3 or 6 mg; day 2, 3 mg), up-dosing (3-300 mg/day for 22-40 weeks, with dose escalations every 2 weeks), and maintenance (300 mg/day for 24-28 weeks).
|
Group 2: Cohort 1 (Age 4-17 QD)
n=109 participants at risk
Received 300 mg/day (once daily, QD) peanut protein for 28 weeks.
|
Group 2: Cohort 2 (Age 4-17 Overall)
n=46 participants at risk
Received 300 mg peanut protein every other day (QOD) for 4 weeks, then twice weekly (BIW) for 24 weeks for a total of 28 weeks.
|
Group 2: Cohort 3A (Age 4-17 QD)
n=31 participants at risk
Received 300 mg/day peanut protein for 56 weeks.
|
Group 2: Cohort 3B (Age 4-17 Overall)
n=31 participants at risk
Cohort 3B: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, then BIW for 24 weeks (total of 56 weeks).
|
Group 2: Cohort 3C (Age 4-17 Overall)
n=34 participants at risk
Cohort 3C: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, BIW for 24 weekly (QW) for 28 weeks (total 84 weeks).
|
Group 1 (Age 18-55 Overall)
n=11 participants at risk
Received AR101 during IDE (day 1, 0.5 to 3 or 6 mg; day 2, 3 mg), up-dosing (3-300 mg/day for 22-40 weeks, with dose escalations every 2 weeks), and maintenance (300 mg/day for 24-28 weeks).
|
Group 2: Cohort 1 (Age 18-55 QD)
n=8 participants at risk
Received 300 mg/day (once daily, QD) peanut protein for 28 weeks.
|
Group 2: Cohort 2 (Age 18-55 Overall)
n=2 participants at risk
Received 300 mg peanut protein every other day (QOD) for 4 weeks, then twice weekly (BIW) for 24 weeks for a total of 28 weeks.
|
Group 2: Cohort 3A (Age 18-55 QD)
n=4 participants at risk
Received 300 mg/day peanut protein for 56 weeks.
|
Group 2: Cohort 3B (Age 18-55 Overall)
n=3 participants at risk
Cohort 3B: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, then BIW for 24 weeks (total of 56 weeks).
|
Group 2: Cohort 3C (Age 18-55 Overall)
n=2 participants at risk
Cohort 3C: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, BIW for 24 weekly (QW) for 28 weeks (total 84 weeks).
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Gastrointestinal disorders
Abdominal pain
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Intestinal perforation
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Streptococcal infection
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Injury, poisoning and procedural complications
Humerus fracture
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.9%
1/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Metabolism and nutrition disorders
Dehydration
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
Other adverse events
| Measure |
Group 1 (Age 4-17 Overall)
n=100 participants at risk
Received AR101 during IDE (day 1, 0.5 to 3 or 6 mg; day 2, 3 mg), up-dosing (3-300 mg/day for 22-40 weeks, with dose escalations every 2 weeks), and maintenance (300 mg/day for 24-28 weeks).
|
Group 2: Cohort 1 (Age 4-17 QD)
n=109 participants at risk
Received 300 mg/day (once daily, QD) peanut protein for 28 weeks.
|
Group 2: Cohort 2 (Age 4-17 Overall)
n=46 participants at risk
Received 300 mg peanut protein every other day (QOD) for 4 weeks, then twice weekly (BIW) for 24 weeks for a total of 28 weeks.
|
Group 2: Cohort 3A (Age 4-17 QD)
n=31 participants at risk
Received 300 mg/day peanut protein for 56 weeks.
|
Group 2: Cohort 3B (Age 4-17 Overall)
n=31 participants at risk
Cohort 3B: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, then BIW for 24 weeks (total of 56 weeks).
|
Group 2: Cohort 3C (Age 4-17 Overall)
n=34 participants at risk
Cohort 3C: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, BIW for 24 weekly (QW) for 28 weeks (total 84 weeks).
|
Group 1 (Age 18-55 Overall)
n=11 participants at risk
Received AR101 during IDE (day 1, 0.5 to 3 or 6 mg; day 2, 3 mg), up-dosing (3-300 mg/day for 22-40 weeks, with dose escalations every 2 weeks), and maintenance (300 mg/day for 24-28 weeks).
|
Group 2: Cohort 1 (Age 18-55 QD)
n=8 participants at risk
Received 300 mg/day (once daily, QD) peanut protein for 28 weeks.
|
Group 2: Cohort 2 (Age 18-55 Overall)
n=2 participants at risk
Received 300 mg peanut protein every other day (QOD) for 4 weeks, then twice weekly (BIW) for 24 weeks for a total of 28 weeks.
|
Group 2: Cohort 3A (Age 18-55 QD)
n=4 participants at risk
Received 300 mg/day peanut protein for 56 weeks.
|
Group 2: Cohort 3B (Age 18-55 Overall)
n=3 participants at risk
Cohort 3B: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, then BIW for 24 weeks (total of 56 weeks).
|
Group 2: Cohort 3C (Age 18-55 Overall)
n=2 participants at risk
Cohort 3C: Received 300 mg/day peanut protein for 28 weeks, QOD for 4 weeks, BIW for 24 weekly (QW) for 28 weeks (total 84 weeks).
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Respiratory, thoracic and mediastinal disorders
Dysphonia
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Blood and lymphatic system disorders
Lymphadenopathy
|
2.0%
2/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Congenital, familial and genetic disorders
Thalassaemia beta
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Ear and labyrinth disorders
Ear pain
|
3.0%
3/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.8%
3/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Ear and labyrinth disorders
Ear pruritus
|
2.0%
2/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
3/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.9%
1/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.2%
2/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Ear and labyrinth disorders
Vertigo
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Eye disorders
Conjunctivitis allergic
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Eye disorders
Eye pruritus
|
8.0%
8/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
4.6%
5/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.7%
4/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
17.6%
6/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.2%
2/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
1/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Abdominal discomfort
|
17.0%
17/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.5%
6/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
10.9%
5/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.8%
3/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
27.3%
3/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Abdominal pain
|
38.0%
38/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
10.1%
11/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
15.2%
7/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
22.6%
7/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
47.1%
16/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
45.5%
5/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
1/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Abdominal pain upper
|
31.0%
31/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.3%
9/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
13.0%
6/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
19.4%
6/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
11.8%
4/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
54.5%
6/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Diarrhoea
|
10.0%
10/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
4.6%
5/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.9%
4/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.9%
4/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.2%
2/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Dyspepsia
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
27.3%
3/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Eosinophilic oesophagitis
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Food poisoning
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Gastrooesophageal reflux disease
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Glossitis
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Hypoaesthesia oral
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Lip pruritus
|
11.0%
11/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.8%
3/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
4.3%
2/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
11.8%
4/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Lip swelling
|
8.0%
8/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.8%
3/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.7%
4/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
11.8%
4/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.2%
2/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Nausea
|
33.0%
33/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.3%
9/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
19.6%
9/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
14.7%
5/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
54.5%
6/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
1/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Oral discomfort
|
1.0%
1/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.9%
1/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Oral pruritus
|
17.0%
17/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.5%
6/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
10.9%
5/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.9%
4/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
20.6%
7/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
27.3%
3/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Paraesthesia oral
|
6.0%
6/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
4.3%
2/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
11.8%
4/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
27.3%
3/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
1/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Swollen tongue
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Tongue pruritus
|
11.0%
11/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.8%
3/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Toothache
|
5.0%
5/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Gastrointestinal disorders
Vomiting
|
42.0%
42/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.5%
18/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
13.0%
6/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
19.4%
6/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
29.0%
9/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
26.5%
9/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
27.3%
3/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
General disorders
Chest discomfort
|
9.0%
9/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.8%
3/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.2%
2/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
General disorders
Chest pain
|
9.0%
9/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.9%
1/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
General disorders
Fatigue
|
4.0%
4/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
1.8%
2/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.9%
1/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
General disorders
Influenza like illness
|
1.0%
1/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
General disorders
Malaise
|
6.0%
6/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
4.3%
2/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.9%
4/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
General disorders
Oedema peripheral
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
General disorders
Pyrexia
|
24.0%
24/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.3%
20/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.7%
4/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.8%
8/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
19.4%
6/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
38.2%
13/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Immune system disorders
Anaphylactic reaction
|
17.0%
17/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.4%
7/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
29.4%
10/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
36.4%
4/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Immune system disorders
Hypersensitivity
|
6.0%
6/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.8%
3/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
2/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Immune system disorders
Seasonal allergy
|
8.0%
8/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
1.8%
2/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.9%
1/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Bronchitis
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Conjunctivitis
|
4.0%
4/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.8%
3/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Ear infection
|
2.0%
2/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.7%
4/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
3/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Enterobiasis
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Gastroenteritis
|
5.0%
5/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
1.8%
2/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.8%
3/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Gastroenteritis viral
|
9.0%
9/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.4%
7/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.9%
1/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Gastrointestinal viral infection
|
2.0%
2/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Influenza
|
7.0%
7/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.4%
7/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.8%
3/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Nasopharyngitis
|
16.0%
16/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
4.6%
5/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
10.9%
5/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
26.5%
9/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
27.3%
3/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
1/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Pharyngitis streptococcal
|
4.0%
4/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
4.6%
5/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
10.9%
5/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Respiratory tract infection viral
|
1.0%
1/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Rhinitis
|
6.0%
6/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.8%
3/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.2%
2/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Sinusitis
|
6.0%
6/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
1.8%
2/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
11.8%
4/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Tonsillitis
|
2.0%
2/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Upper respiratory tract infection
|
23.0%
23/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.3%
20/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
13.0%
6/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
20.6%
7/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
45.5%
5/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
4/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Viral infection
|
10.0%
10/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.3%
9/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
11.8%
4/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.2%
2/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Infections and infestations
Viral upper respiratory tract infection
|
4.0%
4/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
4.6%
5/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.9%
1/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Injury, poisoning and procedural complications
Arthropod bite
|
4.0%
4/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.8%
3/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Injury, poisoning and procedural complications
Arthropod sting
|
1.0%
1/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Injury, poisoning and procedural complications
Laceration
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Injury, poisoning and procedural complications
Ligament sprain
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Injury, poisoning and procedural complications
Procedural pain
|
2.0%
2/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.9%
1/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Injury, poisoning and procedural complications
Road traffic accident
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Injury, poisoning and procedural complications
Soft tissue injury
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Investigations
Breath sounds abnormal
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Investigations
Pulmonary physical examination abnormal
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Metabolism and nutrition disorders
Eating disorder symptom
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Musculoskeletal and connective tissue disorders
Arthralgia
|
2.0%
2/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
1.8%
2/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.9%
1/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Musculoskeletal and connective tissue disorders
Back pain
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
2/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
1/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Musculoskeletal and connective tissue disorders
Neck pain
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
2/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Musculoskeletal and connective tissue disorders
Pain in extremity
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Musculoskeletal and connective tissue disorders
Plantar fasciitis
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lipoma
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Nervous system disorders
Dizziness
|
1.0%
1/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Nervous system disorders
Headache
|
27.0%
27/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
11.0%
12/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
26.1%
12/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.8%
8/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
41.2%
14/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
100.0%
2/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Nervous system disorders
Migraine
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Nervous system disorders
Sinus headache
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Psychiatric disorders
Anxiety
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Reproductive system and breast disorders
Dysmenorrhoea
|
1.0%
1/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
1.8%
2/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Asthma
|
4.0%
4/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.8%
3/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.7%
4/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.9%
4/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
17.6%
6/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.2%
2/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
1/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Choking
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Cough
|
44.0%
44/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
14.7%
16/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
17.4%
8/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.8%
8/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
32.3%
10/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
47.1%
16/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
27.3%
3/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Dry throat
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Dyspnoea
|
12.0%
12/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
14.7%
5/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Nasal congestion
|
22.0%
22/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
7.3%
8/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
13.0%
6/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.9%
4/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
17.6%
6/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Nasal oedema
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Nasal turbinate hypertrophy
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Oropharyngeal pain
|
23.0%
23/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.4%
7/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.7%
4/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
22.6%
7/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
19.4%
6/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
23.5%
8/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
27.3%
3/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
2/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Pharyngeal oedema
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.2%
2/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Pharyngeal paraesthesia
|
2.0%
2/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.8%
3/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
27.3%
3/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Productive cough
|
2.0%
2/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory symptom
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
1/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory tract congestion
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Rhinitis allergic
|
7.0%
7/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.8%
3/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
3/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Rhinorrhoea
|
28.0%
28/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.4%
7/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
4.3%
2/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.9%
4/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
20.6%
7/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
54.5%
6/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Sinus congestion
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Sinus pain
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Sneezing
|
18.0%
18/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
7.3%
8/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.7%
4/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.9%
4/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
11.8%
4/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
36.4%
4/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Throat irritation
|
32.0%
32/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
13.8%
15/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
19.6%
9/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
16.1%
5/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
26.5%
9/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
63.6%
7/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Throat tightness
|
12.0%
12/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Upper-airway cough syndrome
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Respiratory, thoracic and mediastinal disorders
Wheezing
|
17.0%
17/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.8%
3/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
4.3%
2/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
20.6%
7/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
18.2%
2/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Skin and subcutaneous tissue disorders
Dermatitis atopic
|
3.0%
3/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Skin and subcutaneous tissue disorders
Dermatitis contact
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Skin and subcutaneous tissue disorders
Eczema
|
7.0%
7/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
1.8%
2/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.5%
2/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
8.8%
3/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Skin and subcutaneous tissue disorders
Erythema
|
8.0%
8/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.9%
1/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Skin and subcutaneous tissue disorders
Pruritus
|
19.0%
19/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
6.4%
7/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
13.0%
6/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
22.6%
7/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
14.7%
5/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
36.4%
4/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Skin and subcutaneous tissue disorders
Rash
|
14.0%
14/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.5%
6/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.7%
3/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
14.7%
5/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
12.5%
1/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Skin and subcutaneous tissue disorders
Rash generalised
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Skin and subcutaneous tissue disorders
Swelling face
|
1.0%
1/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.92%
1/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.2%
1/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
3.2%
1/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
5.9%
2/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Skin and subcutaneous tissue disorders
Urticaria
|
37.0%
37/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
14.7%
16/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
13.0%
6/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
22.6%
7/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
19.4%
6/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
26.5%
9/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
9.1%
1/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
1/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
2/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Surgical and medical procedures
Rhinoplasty
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
25.0%
1/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Surgical and medical procedures
Sclerotherapy
|
0.00%
0/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
50.0%
1/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
|
Vascular disorders
Flushing
|
6.0%
6/100 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
2.8%
3/109 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
4.3%
2/46 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/31 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/34 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/11 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/8 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/4 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
33.3%
1/3 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
0.00%
0/2 • 28 months
The data is presented separately for the 4-17 year old age group (children and adolescents) and 18-55 year old age group (adults).
|
Additional Information
Director of Regulatory Affairs
Aimmune Therapeutics, Inc.
Phone: 650-409-5164
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee * Institutions cannot publish until the multi-center sponsor publication is published * Or, institutions cannot publish until 18 months after study completion * And Sponsor review of any publications is required prior to any institution publications according to contractual agreements
- Publication restrictions are in place
Restriction type: OTHER